Aquaporin-4 (AQP4) water channels are normally concentrated at astrocyte end-feet ensheathing cerebral microvessels. Early neurodegeneration triggers AQP4 depolarization (mislocalization), impairing glymphatic function before significant neuronal death. Detecting AQP4 mispolarization via CSF biomarkers or soluble AQP4 isoforms enables identification of glymphatic dysfunction. AQP4 represents high therapeutic target potential for glymphatic enhancement, though water channel modulation remains technically challenging.
Curated pathway from expert analysis
flowchart TD
A["Early Neurodegeneration"] --> B["AQP4 Depolarization"]
B --> C["AQP4 Mislocalization from End-feet"]
C --> D["Glymphatic Function Impairment"]
D --> E["Reduced Abeta and Tau Clearance"]
E --> F["Accumulated Neurotoxic Proteins"]
F --> G["Neuronal Dysfunction"]
G --> H["Cognitive Decline"]
C --> I["CSF/Plasma AQP4 Biomarker Detection"]
B --> J["AQP4 as Therapeutic Target"]
J --> K{"AQP4 Re-polarization Therapy"}
K --> L["Glymphatic Enhancement"]
L --> M["Restored Waste Clearance"]
M --> H
style A fill:#ef5350,color:#0d0d1a
style B fill:#ef5350,color:#0d0d1a
style C fill:#ef5350,color:#0d0d1a
style D fill:#ef5350,color:#0d0d1a
style E fill:#ef5350,color:#0d0d1a
style F fill:#ef5350,color:#0d0d1a
style G fill:#ef5350,color:#0d0d1a
style H fill:#ffd54f,color:#0d0d1a
style I fill:#4fc3f7,color:#0d0d1a
style J fill:#81c784,color:#0d0d1a
style K fill:#81c784,color:#0d0d1a
style L fill:#81c784,color:#0d0d1a
style M fill:#81c784,color:#0d0d1aNo linked papers recorded for this hypothesis yet.
Median TPM across 13 brain regions for AQP4 from GTEx v10.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for AQP4.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If CSF/plasma AQP4 polarization index (AQP4 perivascular astrocyte coverage) is a glymphatic function biomarker, then reduced AQP4 polarization (low CSF/serum AQP4 ratio) will predict glymphatic dysfu | In patients with overnight CSF tracer study (n≥60), low CSF/serum AQP4 ratio (<median) associates with 30-40% slower tracer clearance from CSF (k<0.15 vs k>0.20 | — no observation — | pending | 0.75 |